Meyka Pro banner
Zomedica Corp.

Zomedica Corp. (ZOM) Stock Overview

Explore Zomedica Corp.’s financial performance, market position, analyst ratings, and future outlook.

ZOMAMEX
HealthcareDrug Manufacturers - Specialty & Generic
$0.10
$0.00(0.21%)
U.S. Market is Open · 13:56

Zomedica Corp. (ZOM)

Meyka AI Score

Z

Key Financials

Market Cap95.3M
P/E Ratio-5.29
EPS (TTM)$-0.06
ROE-0.17%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

ZOM Stock Analysis & Investment Overview (AMEX)

Our AI-powered analysis of Zomedica Corp. (AMEX: ZOM) gives investors deep insight into how the stock performs on the AMEX exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Zomedica Corp.'s AMEX-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ZOM on the AMEX shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the AMEX listing.

Key metrics behind Zomedica Corp.'s AMEX-traded stock include a P/E ratio of -5.29 and a market capitalization of 95.3M. Combined with our AI analysis, these give both institutional and retail investors a clear view of ZOM on the AMEX.

Price Performance (AMEX: ZOM)

1-Day Change
N/A
5-Day Change
62.17%
1-Month Change
-0.21%
3-Month Change
-33.76%
6-Month Change
-25.15%
Year-to-Date (YTD) Change
-29.59%
1-Year Change
-31.58%
3-Year Change
-71.36%
5-Year Change
-40.53%
All-Time (Max) Change
-88.26%

Contact Information

734 369 2555
100 Phoenix Drive, Ann Arbor, MI, 48108

Company Facts

1,440 Employees
IPO DateNov 21, 2017
CountryUS

Frequently Asked Questions